These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 29594318)
1. Adrenal crisis after first infusion of zoledronic acid: a case report. Smrecnik M; Kavcic Trsinar Z; Kocjan T Osteoporos Int; 2018 Jul; 29(7):1675-1678. PubMed ID: 29594318 [TBL] [Abstract][Full Text] [Related]
2. Adrenal Crisis as An Adverse Reaction to Zoledronic Acid in a Patient With Primary Adrenal Insufficiency: A Case Report and Literature Review. Kuo B; Koransky A; Vaz Wicks CL AACE Clin Case Rep; 2023; 9(2):32-34. PubMed ID: 37056413 [TBL] [Abstract][Full Text] [Related]
3. Multicenter Study on Observation of Acute-phase Responses After Infusion of Zoledronic Acid 5 mg in Chinese Women with Postmenopausal Osteoporosis. Ding Y; Zeng JC; Yin F; Zhang CL; Zhang Y; Li SX; Liu X; Zhang C; Xue QY; Lin H; Pei FX Orthop Surg; 2017 Aug; 9(3):284-289. PubMed ID: 28960821 [TBL] [Abstract][Full Text] [Related]
4. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency]. Fichna M; Gryczyńska M; Sowińska A; Sowiński J Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518 [TBL] [Abstract][Full Text] [Related]
5. [Addison's disease]. Quinkler M Med Klin Intensivmed Notfmed; 2012 Sep; 107(6):454-9. PubMed ID: 22907517 [TBL] [Abstract][Full Text] [Related]
11. Recurrent nocturnal hypoglycaemia as a cause of morning fatigue in treated Addison's disease--favourable response to dietary management: a case report. Petersen KS; Rushworth RL; Clifton PM; Torpy DJ BMC Endocr Disord; 2015 Oct; 15():61. PubMed ID: 26500000 [TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate-induced orbital inflammation in a patient on chronic immunosuppressive therapy. Herrera I; Kam Y; Whittaker TJ; Champion M; Ajlan RS BMC Ophthalmol; 2019 Feb; 19(1):51. PubMed ID: 30764790 [TBL] [Abstract][Full Text] [Related]
13. Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study. Liang BC; Shi ZY; Wang B; Wu P; Kong LC; Yao JL; Li CW; Shi XL Orthop Surg; 2017 Feb; 9(1):103-109. PubMed ID: 28276638 [TBL] [Abstract][Full Text] [Related]
14. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis. Cosman F; Eriksen EF; Recknor C; Miller PD; Guañabens N; Kasperk C; Papanastasiou P; Readie A; Rao H; Gasser JA; Bucci-Rechtweg C; Boonen S J Bone Miner Res; 2011 Mar; 26(3):503-11. PubMed ID: 20814967 [TBL] [Abstract][Full Text] [Related]
15. Bone mineral density in patients with treated Addison's disease. Braatvedt GD; Joyce M; Evans M; Clearwater J; Reid IR Osteoporos Int; 1999; 10(6):435-40. PubMed ID: 10663342 [TBL] [Abstract][Full Text] [Related]